Skip to main content

Advertisement

Log in

Loss of glycosylation associated with the T183A mutation in human prion disease

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

A heterozygous T183A mutation in the prion protein (PrP) gene, PRNP, was identified in a patient with histopathologically confirmed spongiform encephalopathy. Clinically, this form of prion disease was characterized by early-onset dementia as the predominant sign, along with global cerebral atrophy and hypometabolism. The age at onset was 40 years and the disease duration was 4 years. Additional neurological signs including cerebellar ataxia and EEG abnormalities were absent until late stages of the disease. The T183A mutation was not found in non-affected family members. This mutation results in the removal of one of the two consensus sites for glycosylation of PrP. Neuropathological examination revealed severe spongiform degeneration and neuronal loss in the neocortex, putamen and claustrum, small plaque-like PrP-immunoreactive deposits in the molecular layer of the cerebellum, and faint intracellular cytoplasmic PrP immunoreactivity. Western blot analysis of the patient’s brain tissue showed protease K-resistant PrP with a definite preponderance of the monoglycosylated form. The additional appearance of a band representing diglycosylated PrPSc strongly suggests that non-mutated PrP also acquires protease resistance in the present setting. Cell culture experiments confirmed previous reports on intracellular retention of the mutant protein in vitro. This is the second report of a disease-causing T183A mutation of PrP, and the clinical, histological and genetic observations strongly suggest that T183A is a disease-causing mutation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2 a
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Boellaard JW, Doerrschott J, Schlote W (1993) Miniplaques and shapeless cerebral amyloid deposits in a case of Gerstmann-Straussler-Scheinker’s syndrome. Acta Neuropathol 86:532–535

    CAS  PubMed  Google Scholar 

  2. Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887–890

    CAS  PubMed  Google Scholar 

  3. Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB (2000) The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. J Alzheimers Dis 2:27–35

    CAS  PubMed  Google Scholar 

  4. Chen SG, Parchi P, Brown P, Capellari S, Zou W, Cochran EJ, Vnencak-Jones CL, Julien J, Vital C, Mikol J, Lugaresi E, Gambetti P (1997) Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med 3:1009–1015

    Article  CAS  PubMed  Google Scholar 

  5. Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, Baker H, Crow TJ, Lofthouse R, Poulter M, Ridley R, et al (1992) Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 115:687–710

    PubMed  Google Scholar 

  6. DeArmond S, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB (1997) Selective neuronal targeting in prion disease. Neuron 19:1337–1348

    Article  CAS  PubMed  Google Scholar 

  7. DeArmond SJ, Bouzamondo E (2002) Fundamentals of prion biology and diseases. Toxicology 181–182:9–16

    Google Scholar 

  8. Finckh U, ller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W, Binetti G, Alberici A, Hock C, Nitsch RM, Gal A (2000) High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet 66:110–117

    Article  CAS  PubMed  Google Scholar 

  9. Fisher CL, Pei GK (1997) Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23:570–574

    CAS  PubMed  Google Scholar 

  10. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  CAS  PubMed  Google Scholar 

  11. Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med 2:59–64

    Article  CAS  PubMed  Google Scholar 

  12. Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, Tagliavini F (1995) Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol 5:61–75

    CAS  PubMed  Google Scholar 

  13. Goldfarb LG, Petersen RB, Tabaton M, Brown P, Leblanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Gajdusek DC, Lugaresi E, Gambetti P (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808

    CAS  PubMed  Google Scholar 

  14. Hainfellner J-A, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H (1999) A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 45:812–815

    Article  CAS  PubMed  Google Scholar 

  15. Hamasaki S, Shirabe S, Tsuda R, Yoshimura T, Nakamura T, Eguchi K (1998) Discordant Gerstmann-Straussler-Scheinker disease in monozygotic twins. Lancet 352:1358–1359

    CAS  Google Scholar 

  16. Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, Ironside JW, Collinge J (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:1333–1346

    Article  PubMed  Google Scholar 

  17. Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421

    Article  CAS  PubMed  Google Scholar 

  18. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688–3693

    CAS  PubMed  Google Scholar 

  19. Klebe RJ, Ruddle FH (1969) Neuroblastoma: cell culture analysis of a differentiating stem cell system. J Cell Biol 43:69a

    Google Scholar 

  20. Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582

    Google Scholar 

  21. Kretzschmar HA, Sethi S, Foldvari Z, Windl O, Querner V, Zerr I, Poser S (2003) Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol 13:245–249

    PubMed  Google Scholar 

  22. Lehmann S, Harris DA (1997) Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem 272:21479–21487

    Article  CAS  PubMed  Google Scholar 

  23. Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258–3267

    Article  CAS  PubMed  Google Scholar 

  24. Lorenz H, Windl O, Kretzschmar HA (2001) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516

    Article  PubMed  Google Scholar 

  25. Luhrs T, Riek R, Guntert P, Wuthrich K (2003) NMR structure of the human doppel protein. J Mol Biol 326:1549–1557

    Article  CAS  PubMed  Google Scholar 

  26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944

    CAS  PubMed  Google Scholar 

  27. Negro A, Ballarin C, Bertoli A, Massimino ML, Sorgato MC (2001) The Metabolism and imaging in live cells of the bovine prion protein in its native form or carrying single amino acid substitutions. Mol Cell Neurosci 17:521–538

    Google Scholar 

  28. Nitrini R, Rosemberg S, Passos-Bueno MR, Teixeira da Silva LS, Iughetti P, Papadopoulos M, Carrilho PM, Caramelli P, Albrecht S, Zatz M, et al. (1997) Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 42:138–146

    CAS  PubMed  Google Scholar 

  29. Nixon R, Camicioli R, Jamison K, Cervenakova L, Mastrianni JA (2000) The PRNP-V180I mutation is associated with abnormally glycosylated PrP and intracellular PrP accumulations. Brain Pathol 10:670

    Google Scholar 

  30. Owen F, Poulter M, Shah T, Collinge J, Lofthouse R, Baker H, Ridley R, McVey J, Crow TJ (1990) An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Mol Brain Res 7:273–276

    Google Scholar 

  31. Parchi P, Chen SG, Brown P, Zou WQ, Capellari S, Budka H, Hainfellner J, Reyes PF, Golden GT, Hauw J-J, et al (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci USA 95:8322–8328

    Article  CAS  PubMed  Google Scholar 

  32. Parchi P, Petersen RB, Chen SG, Autillo-Gambetti L, Capellari S, Monari L, Cortelli P, Montagna P, Lugaresi E, Gambetti P (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8:539–548

    CAS  PubMed  Google Scholar 

  33. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233

    Article  CAS  PubMed  Google Scholar 

  34. Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wüthrich K (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci USA 95:11667–11672

    Article  CAS  PubMed  Google Scholar 

  35. Rogers M, Taraboulos A, Scott M, Groth D, Prusiner SB (1990) Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1:101–109

    CAS  PubMed  Google Scholar 

  36. Rudd PM, Wormald MR, Wing DR, Prusiner SB, Dwek RA (2001) Prion glycoprotein: structure, dynamics, and roles for the sugars. Biochemistry 40:3759–3766

    Article  CAS  PubMed  Google Scholar 

  37. Silvestrini MC, Cardone F, Maras B, Pucci P, Barra D, Brunori M, Pocchiari M (1997) Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeld-Jakob disease patients. Nat Med 3:521–525

    Article  CAS  PubMed  Google Scholar 

  38. Tagliavini F, Prelli F, Porro M, Rossi G, Giaccone G, Farlow MR, Dlouhy SR, Ghetti B, Bugiani O, Frangione B (1994) Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79:695–704

    Article  CAS  PubMed  Google Scholar 

  39. Vorberg I, Buschmann A, Harmeyer S, Saalmüller A, Pfaff E, Groschup M (1999) A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology 255:26–31

    Article  CAS  PubMed  Google Scholar 

  40. Windl O, Dempster M, Estibeiro JP, Lathe R, De Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KCL, Palmer MS, Collinge J (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variations in the PRNP gene. Hum Genet 98:259–264

    Article  CAS  PubMed  Google Scholar 

  41. Windl O, Giese A, Schulz-Schaeffer W, Skworc K, Arendt S, Oberdieck C, Bodemer M, Zerr I, Poser S, Kretzschmar HA (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105:244–252

    Article  CAS  PubMed  Google Scholar 

  42. Young K, Clark HB, Piccardo P, Dlouhy SR, Ghetti B (1997) Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Mol Brain Res 44:147–150

    Article  CAS  PubMed  Google Scholar 

  43. Zahn R, Liu A, Luhrs T, Riek R, Schroetter C von, Lopez GF, Billeter M, Calzolai L, Wider G, Wuthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145–150

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the Federal Ministry of Health (325-4471–02/15). Dr. R. Lederer is gratefully acknowledged for help in the preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. A. Kretzschmar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grasbon-Frodl, E., Lorenz, H., Mann, U. et al. Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol 108, 476–484 (2004). https://doi.org/10.1007/s00401-004-0913-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-004-0913-4

Keywords

Navigation